Human medicines European public assessment report (EPAR): Svariya (previously Rivaroxaban Koanaa), rivaroxaban, Date of authorisation: 21/11/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Svariya (previously Rivaroxaban Koanaa), rivaroxaban, Date of authorisation: 21/11/2025, Revision: 1, Status: Authorised

European platform for regulatory science research meeting: October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2026, 09:00 (CEST) to 22 October 2026, 17:00 (CEST)

European platform for regulatory science research meeting: October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2026, 09:00 (CEST) to 22 October 2026, 17:00 (CEST)

Fifth European Medicines Agency (EMA) and Affordable Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 11 September 2026

Fifth European Medicines Agency (EMA) and Affordable Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 11 September 2026

Ninth European Medicines Agency (EMA) and EFPIA bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 September 2026, 10:30 (CEST) to 16 September 2026, 12:30 (CEST)

Ninth European Medicines Agency (EMA) and EFPIA bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 September 2026, 10:30 (CEST) to 16 September 2026, 12:30 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness